| Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 431.10M | 367.25M | 382.39M | 374.81M | 302.63M |
| Gross Profit | 198.91M | 175.91M | 187.31M | 177.16M | 140.25M |
| EBITDA | 55.56M | 54.47M | 73.33M | 56.23M | 51.15M |
| Net Income | 42.50M | 35.56M | 48.72M | 41.65M | 35.77M |
Balance Sheet | |||||
| Total Assets | 273.51M | 267.06M | 278.84M | 233.60M | 207.22M |
| Cash, Cash Equivalents and Short-Term Investments | 82.81M | 131.19M | 123.46M | 108.30M | 76.61M |
| Total Debt | 6.14M | 5.56M | 5.90M | 1.38M | 3.36M |
| Total Liabilities | 173.05M | 129.07M | 122.03M | 104.25M | 99.53M |
| Stockholders Equity | 100.46M | 137.99M | 156.81M | 129.35M | 107.69M |
Cash Flow | |||||
| Free Cash Flow | 52.77M | 55.44M | 67.35M | 60.79M | 38.82M |
| Operating Cash Flow | 60.81M | 58.81M | 73.02M | 63.29M | 44.64M |
| Investing Cash Flow | -16.62M | 7.86M | -27.15M | -2.50M | -4.63M |
| Financing Cash Flow | -90.33M | -59.69M | -28.36M | -29.37M | -26.53M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | £948.45M | 20.57 | 25.32% | 2.85% | 17.39% | 24.30% | |
70 Outperform | £508.50M | 71.10 | 1.53% | 1.73% | -0.18% | 11.49% | |
68 Neutral | £213.25M | 37.63 | 5.22% | 0.80% | 19.00% | -53.85% | |
65 Neutral | £327.56M | 41.80 | 7.57% | 1.04% | 2.55% | 16.38% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
58 Neutral | £125.47M | 15.12 | 7.38% | 1.92% | -7.27% | -15.76% | |
54 Neutral | £380.02M | 102.96 | 7.75% | 2.16% | ― | ― |